Shares of Cardlytics, Inc. (NASDAQ:CDLX – Get Rating) traded up 9.8% during mid-day trading on Tuesday . The company traded as high as $25.50 and last traded at $25.45. 9,038 shares traded hands during mid-day trading, a decline of 98% from the average session volume of 454,290 shares. The stock had previously closed at $23.18. […]
Equities analysts expect Cardlytics, Inc. (NASDAQ:CDLX – Get Rating) to report ($0.54) earnings per share (EPS) for the current fiscal quarter, Zacks reports. Two analysts have provided estimates for Cardlytics’ earnings. The highest EPS estimate is ($0.46) and the lowest is ($0.61). Cardlytics reported earnings per share of ($0.39) during the same quarter last year, […]
Cardlytics (NASDAQ:CDLX – Get Rating) had its price objective decreased by Needham & Company LLC from $85.00 to $60.00 in a research note issued on Tuesday, The Fly reports. Needham & Company LLC’s price objective would indicate a potential upside of 67.32% from the company’s previous close. CDLX has been the subject of a number […]
Cardlytics (NASDAQ:CDLX – Get Rating) is scheduled to be issuing its quarterly earnings data after the market closes on Monday, May 2nd. Analysts expect the company to announce earnings of ($1.11) per share for the quarter. Parties that are interested in registering for the company’s conference call can do so using this link. Cardlytics (NASDAQ:CDLX […]
Cardlytics, Inc. (NASDAQ:CDLX – Get Rating) Director Scott D. Grimes sold 4,098 shares of the company’s stock in a transaction on Tuesday, April 19th. The stock was sold at an average price of $50.09, for a total value of $205,268.82. Following the sale, the director now owns 243,606 shares of the company’s stock, valued at […]